Evidence map›Paper›PMID 37575322›Full record

ReviewFrontiers in nutrition2023

Ketogenic diet: a potential adjunctive treatment for substance use disorders.

Deshenyue Kong, Jia-Xue Sun, Ji-Qun Yang, Yuan-Sen Li, Ke Bi, Zun-Yue Zhang, Kun-Hua Wang, Hua-You Luo, Mei Zhu, Yu Xu

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in nutrition, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Novel neurotherapeutic targets for substance use disorders: Neuroplasticity, neuroinflammation, gasotransmitters and non-canonical organ systems.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  5. Modulation of pain by ketones: a mini-review.American journal of physiology. Cell physiology · 2025
    Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Deshenyue KongGeneral Hospital of Eastern Theater Command, Nanjing, China.
Jia-Xue SunYunnan Technological Innovation Centre of Drug Addiction Medicine, Yunnan University, Kunming, China.
Ji-Qun YangThird People's Hospital of Kunming City/Drug Rehabilitation Hospital of Kunming City, Kunming, China.
Yuan-Sen LiYunnan Technological Innovation Centre of Drug Addiction Medicine, Yunnan University, Kunming, China.
Ke BiYunnan Technological Innovation Centre of Drug Addiction Medicine, Yunnan University, Kunming, China.
Zun-Yue ZhangYunnan Technological Innovation Centre of Drug Addiction Medicine, Yunnan University, Kunming, China.
Kun-Hua WangYunnan Technological Innovation Centre of Drug Addiction Medicine, Yunnan University, Kunming, China.
Hua-You LuoFirst Affiliated Hospital of Kunming Medical University, Kunming, China.
Mei ZhuFirst Affiliated Hospital of Kunming Medical University, Kunming, China.
Yu XuGeneral Hospital of Eastern Theater Command, Nanjing, China.
Kunming Medical University · CNYunnan University · CNFirst Affiliated Hospital of Kunming Medical University · CNKunming Third People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Substance use disorders (SUD) can lead to serious health problems, and there is a great interest in developing new treatment methods to alleviate the impact of substance abuse. In recent years, the ketogenic diet (KD) has shown therapeutic benefits as a dietary therapy in a variety of neurological disorders. Recent studies suggest that KD can compensate for the glucose metabolism disorders caused by alcohol use disorder by increasing ketone metabolism, thereby reducing withdrawal symptoms and indicating the therapeutic potential of KD in SUD. Additionally, SUD often accompanies increased sugar intake, involving neural circuits and altered neuroplasticity similar to substance addiction, which may induce cross-sensitization and increased use of other abused substances. Reducing carbohydrate intake through KD may have a positive effect on this. Finally, SUD is often associated with mitochondrial damage, oxidative stress, inflammation, glia dysfunction, and gut microbial disorders, while KD may potentially reverse these abnormalities and serve a therapeutic role. Although there is much indirect evidence that KD has a positive effect on SUD, the small number of relevant studies and the fact that KD leads to side effects such as metabolic abnormalities, increased risk of malnutrition and gastrointestinal symptoms have led to the limitation of KD in the treatment of SUD. Here, we described the organismal disorders caused by SUD and the possible positive effects of KD, aiming to provide potential therapeutic directions for SUD.

Indexed as

addictiongut microbiotaketogenic dietmetabolismneuroprotectionsubstance use disorders

Identifiers

PMID37575322
PMCPMC10414993
OpenAlexW4385301607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.